Erratum: Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.

Hendlisz, Alain;Golfinopoulos, Vassilis;Deleporte, Amelie;Paesmans, Marianne;Flamen, Patrick;et.al.
(2015) BMC Cancer — Vol. 15, n° 1, p. 173 (2015)

Files

2015_Hendlisz_BMC_Cancer.pdf
  • Open Access
  • Adobe PDF
  • 244 KB
Download

Details

Authors
  • Hendlisz, Alain
    Author
  • Golfinopoulos, Vassilis
    Author
  • Deleporte, Amelie
    Author
  • Paesmans, Marianne
    Author
  • Van den Eynde, MarcUCLouvain
    Author
  • Borbath, IvanUCLouvain
    Author
  • Flamen, Patrick
    Author
Show more
Abstract
Erratum for Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study. [BMC Cancer. 2013]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Hendlisz, A., Golfinopoulos, V., Deleporte, A., Paesmans, M., El Mansy, H., Garcia, C., Peeters, M., Annemans, L., Vandeputte, C., Maetens, M., Van den Eynde, M., Maréchal, R., Borbath, I., Dresse, D., Houbiers, G., Fried, M., Awada, A., Piccart, M., Van Laethem, J.-L., & Flamen, P. (2015). Erratum: Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study. BMC Cancer, 15(1), 173. https://doi.org/10.1186/s12885-015-1181-5 (Original work published 2015)